News

All News

RLS Expands by Offering Radiopharmaceutical Contract Development and Manufacturing (rCDMO) Services

Date: 10.26.2023

Download

What the Radiopharmaceutical Pipeline Means for Patient Care

Date: 10.16.2023

Download

The Supply and Availability of Radiopharmaceuticals

Date: 08.25.2023

Download

RADIOPHARMACY NETWORK RLS ANNOUNCES EXECUTIVE APPOINTMENTS IN SALES AND HUMAN RESOURCES

Date: 06.22.2023

Download

RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS

Date: 06.21.2023

Download

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS

Date: 06.13.2023

Download

SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost

Date: 06.07.2023

Download

RLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc.

Date: 06.05.2023

Download

RLS & Evergreen Partnership for Drug Candidate OCTEVY™

Date: 05.18.2023

Download

QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam

Date: 05.16.2023

Download

Connect With Us

We’re here to help. If you have an order or account related question or concern, please contact your RLS Account Manager directly or call your local RLS Radiopharmacy at 800 242 8004.

For additional inquiries, please visit our contact page and select from the list below:
General, Business Support, Careers, Media

connect with us